biotin has been researched along with Triple Negative Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abedi, M; Javanmardi, S; Mohammad Tamaddon, A; Mohebi, Y; Najafi, H; Sadat Abolmaali, S; Zarenejad, S | 1 |
| Gu, W; Hanaoka, H; Katsumata, N; Tsushima, Y; Yudistiro, R | 1 |
| Hanaoka, H; Katsumata, N; Tsushima, Y; Yamaguchi, A; Yudistiro, R | 1 |
3 other study(ies) available for biotin and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Biotin receptor-targeting nanogels loaded with methotrexate for enhanced antitumor efficacy in triple-negative breast cancer in vitro and in vivo models.
Topics: Animals; Biotin; Drug Carriers; Drug Delivery Systems; Humans; Methotrexate; Mice; Nanogels; Receptors, Growth Factor; Triple Negative Breast Neoplasms | 2022 |
Potential of three-step pretargeting radioimmunotherapy using biotinylated bevacizumab and succinylated streptavidin in triple-negative breast cancer xenograft.
Topics: Animals; Antineoplastic Agents, Immunological; Bevacizumab; Biotin; Dose-Response Relationship, Immunologic; Female; Heterografts; Immunoconjugates; Indium; Indium Radioisotopes; Kidney; Mice; Mice, Inbred BALB C; Mice, Nude; Radioimmunotherapy; Streptavidin; Succinimides; Triple Negative Breast Neoplasms | 2021 |
Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase.
Topics: Animals; Avidin; Bevacizumab; Biotin; Cell Line, Tumor; Female; Humans; Immunoconjugates; Metabolic Clearance Rate; Mice, Inbred BALB C; Mice, Nude; Radioimmunotherapy; Tissue Distribution; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2018 |